Literature DB >> 16286385

Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas?

Tufail F Patankar1, Hamied A Haroon, Samantha J Mills, Danielle Balériaux, David L Buckley, Geoff J M Parker, Alan Jackson.   

Abstract

PURPOSE: The purpose of this study was to examine the relationship between contrast transfer coefficient [K(trans)] and grade in gliomas.
MATERIAL AND METHODS: Median values of K(trans), CBV(T1), and of the 95th percentile (95%) of the distribution (K(trans) [95%] and CBV(T1) [95%]) were calculated in 39 patients with glioma. Group comparisons and post hoc pairwise comparisons were performed. The relationship between variables and grade used Spearman rho and canonical discriminant analysis. The separation of high- from low-grade tumors was separately assessed by using Mann-Whitney U tests and logistic regression. Receiver operator curve analysis was performed for high- and low-grade tumors and grade III and grade IV tumors.
RESULTS: There were significant differences between grades for all variables (P < .001). Pairwise comparisons demonstrated significant differences between grades II and III and II and IV for all variables except K(trans), which did not show significance in the grade II and III comparison, and between III and IV for CBV(T1) and CBV(T1) (95%; P < .01). All variables correlated with grade (P < .01). Discriminant analysis showed independent relation between both CBV(T1) and K(trans) (95%) and grade, and the canonical function produced a total correct classification of 74.4% of cases. Logistic regression analysis for low- versus high-grade tumors showed K(trans) (95%) and CBV(T1) to be independent factors (P < .01 and P < .05).
CONCLUSION: There are strong independent relationships between both CBV and K(trans) and histologic grade in gliomas. Both measurements show good discriminative power in distinguishing between low- and high-grade tumors with diagnostic sensitivity and specificity >90%.

Entities:  

Mesh:

Year:  2005        PMID: 16286385      PMCID: PMC7976173     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  43 in total

1.  Perfusion MR imaging of brain neoplasms.

Authors:  J C Wong; J M Provenzale; J R Petrella
Journal:  AJR Am J Roentgenol       Date:  2000-04       Impact factor: 3.959

2.  Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity.

Authors:  A Kassner; D J Annesley; X P Zhu; K L Li; I D Kamaly-Asl; Y Watson; A Jackson
Journal:  J Magn Reson Imaging       Date:  2000-02       Impact factor: 4.813

3.  Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data.

Authors:  K L Li; X P Zhu; D R Checkley; J J L Tessier; V F Hillier; J C Waterton; A Jackson
Journal:  Br J Radiol       Date:  2003-01       Impact factor: 3.039

4.  Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma.

Authors:  A Jackson; G C Jayson; K L Li; X P Zhu; D R Checkley; J J L Tessier; J C Waterton
Journal:  Br J Radiol       Date:  2003-03       Impact factor: 3.039

5.  Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy.

Authors:  M Fuss; F Wenz; M Essig; M Muenter; J Debus; T S Herman; M Wannenmacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

6.  Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma.

Authors:  D Croteau; L Scarpace; D Hearshen; J Gutierrez; J L Fisher; J P Rock; T Mikkelsen
Journal:  Neurosurgery       Date:  2001-10       Impact factor: 4.654

7.  A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas.

Authors:  Hamied A Haroon; David L Buckley; Tufail A Patankar; Graham R Dow; Scott A Rutherford; Danielle Balériaux; Alan Jackson
Journal:  J Magn Reson Imaging       Date:  2004-05       Impact factor: 4.813

8.  Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.

Authors:  Meng Law; Stanley Yang; James S Babb; Edmond A Knopp; John G Golfinos; David Zagzag; Glyn Johnson
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

9.  Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade.

Authors:  H C Roberts; T P Roberts; R C Brasch; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

10.  Measuring blood volume and vascular transfer constant from dynamic, T(2)*-weighted contrast-enhanced MRI.

Authors:  Glyn Johnson; Stephan G Wetzel; Soonmee Cha; James Babb; Paul S Tofts
Journal:  Magn Reson Med       Date:  2004-05       Impact factor: 4.668

View more
  45 in total

Review 1.  Update on brain tumor imaging: from anatomy to physiology.

Authors:  S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

2.  Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas.

Authors:  Na Zhang; Lijuan Zhang; Bensheng Qiu; Li Meng; Xiaoyi Wang; Bob L Hou
Journal:  J Magn Reson Imaging       Date:  2012-05-11       Impact factor: 4.813

3.  Diagnostic accuracy of dynamic contrast-enhanced MR imaging using a phase-derived vascular input function in the preoperative grading of gliomas.

Authors:  T B Nguyen; G O Cron; J F Mercier; C Foottit; C H Torres; S Chakraborty; J Woulfe; G H Jansen; J M Caudrelier; J Sinclair; M J Hogan; R E Thornhill; I G Cameron
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-22       Impact factor: 3.825

4.  Pixel-by-Pixel Comparison of Volume Transfer Constant and Estimates of Cerebral Blood Volume from Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast-Enhanced MR Imaging in High-Grade Gliomas.

Authors:  P Alcaide-Leon; D Pareto; E Martinez-Saez; C Auger; A Bharatha; A Rovira
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-29       Impact factor: 3.825

5.  Intratumor distribution and test-retest comparisons of physiological parameters quantified by dynamic contrast-enhanced MRI in rat U251 glioma.

Authors:  Madhava P Aryal; Tavarekere N Nagaraja; Stephen L Brown; Mei Lu; Hassan Bagher-Ebadian; Guangliang Ding; Swayamprava Panda; Kelly Keenan; Glauber Cabral; Tom Mikkelsen; James R Ewing
Journal:  NMR Biomed       Date:  2014-08-14       Impact factor: 4.044

Review 6.  Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.

Authors:  G Thompson; S J Mills; D J Coope; J P B O'Connor; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 7.  Biology, genetics and imaging of glial cell tumours.

Authors:  C Walker; A Baborie; D Crooks; S Wilkins; M D Jenkinson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

8.  Multimodal MR imaging model to predict tumor infiltration in patients with gliomas.

Authors:  Christopher R Durst; Prashant Raghavan; Mark E Shaffrey; David Schiff; M Beatriz Lopes; Jason P Sheehan; Nicholas J Tustison; James T Patrie; Wenjun Xin; W Jeff Elias; Kenneth C Liu; Greg A Helm; A Cupino; Max Wintermark
Journal:  Neuroradiology       Date:  2013-12-15       Impact factor: 2.804

Review 9.  Current Clinical Brain Tumor Imaging.

Authors:  Javier E Villanueva-Meyer; Marc C Mabray; Soonmee Cha
Journal:  Neurosurgery       Date:  2017-09-01       Impact factor: 4.654

10.  Enhancing fraction in glioma and its relationship to the tumoral vascular microenvironment: A dynamic contrast-enhanced MR imaging study.

Authors:  S J Mills; C Soh; J P B O'Connor; C J Rose; G Buonaccorsi; S Cheung; S Zhao; G J M Parker; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-17       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.